Contact Us
Cecolin 9 Info
Join IX

Global Distribution

We deliver HPV vaccines worldwide through a robust and scalable distribution system.

Vaccine Portfolio Global Distribution
Global Distribution

Global Vaccine Distribution

IX has established a global vaccine distribution network to ensure safe, reliable and efficient delivery of vaccines worldwide. Every stage of the distribution process is managed under strict quality and regulatory standards to maintain product integrity.

Global Vaccine Distribution
Global Vaccine Distribution
Global Vaccine Distribution

Diverse Global Partnership Network

IX has established partnerships with healthcare institutions, government agencies, and international organizations across more than 30 countries and regions, accelerating the global reach of high-quality vaccines and empowering local vaccine manufacturing via technology transfer.

Angola

Angola
Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：1 dose
Target Population - Sex：Female
Current Timing of Vaccine Doses：9-12 years

Bangladesh

Burkina Faso

Belarus

Belarus
Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：2 doses
Target Population - Sex：Female
Current Timing of Vaccine Doses：11-14 years

Burundi

China

China
Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：2 doses
Target Population - Sex：Female
Current Timing of Vaccine Doses：13 years

Cambodia

Cuba

Cuba
Cuba implemented Cecolin vaccination to protect against human papillomavirus (HPV)

DR Congo

Egypt

Ethiopia

Ghana

Guatemala

India

India
Hecolin was successfully launched in India to help prevent hepatitis E virus infection

Indonesia

Kazakhstan

Kenya

Madagascar

Madagascar
Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：1 dose
Target Population - Sex：Female
Current Timing of Vaccine Doses：9-14 years

Mali

Mexico

Morocco

Myanmar

Nepal

Nepal
Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：1 dose
Target Population - Sex：Female
Current Timing of Vaccine Doses：10-14 years

Nicaragua

Nicaragua
Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：2 doses
Target Population - Sex: Female
Current Timing of Vaccine Doses：12-14 years

Niger

Nigeria

Pakistan

Pakistan
Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：1 dose
Target Population - Sex：Female
Current Timing of Vaccine Doses：9-14 years during campaign

Pakistan

Hecolin is approved and has been used in Pakistan, primarily in targeted or outbreak-related vaccination settings

South Sudan

SouthSudan
Market Type：Mass Campagin
Current or Planned Formulation：Hecolin (HEV)
Current Dosing Schedule：following PIL

Thailand

Thailand
Cecolin (Bivalent HPV Vaccine):
Supplied Market Type: National Immunization Program (EPI)
Inoculation Schedule: 1 Dose
Target Population: Females
Cecolin 9 (Nonavalent/9-valent HPV Vaccine):
Market Status: Approved and recommended for inclusion in the National Immunization Program (EPI)
Preventra 9 (Nonavalent/9-valent HPV Vaccine, Tech-transfer Product):
Market Status: Approved and recommended for inclusion in the National Immunization Program (EPI)

Tunisia

Market Type：EPI
Current or Planned Formulation：Cecolin (HPV-2)
Current Dosing Schedule：1 dose
Target Population - Sex：Female
Current Timing of Vaccine Doses：12 years

30+

Countries Accessed

10+

EPI

Cecolin Portfolio
Hecolin
Distribution Process

Distribution Process

IX follows a standardized distribution process to ensure vaccine quality and temperature control throughout the supply chain.

  • Vaccine Production and Quality Release
  • Controlled Cold Storage (2-8°C)
  • Temperature-Controlled Packaging
  • International Cold-Chain Transportation
  • Delivery to Global Partners and Customers

Cold Chain Management

Maintaining stable temperature conditions is essential to preserving vaccine quality. IX operates advanced cold-chain facilities and transportation solutions to ensure temperature stability throughout the entire distribution process.

Cold Storage Facility

  • Precision-controlled temperature and humidity environment
  • Continuous monitoring system with real-time data recording

Temperature-Controlled Packaging

These packaging solutions support both routine deliveries and large-volume international vaccine shipments while ensuring temperature compliance.

1. Passive Cold Chain Shipping Containers

  • Insulated shipping containers with qualified refrigerants
  • Maintain temperature 2–8 °C within validated shipping duration
  • Suitable for routine vaccine distribution shipments

2. Active Cold Chain Shipping Containers

  • Powered temperature control system
  • Suitable for long-distance or high-value shipments

Cold-Chain Monitoring

  • Electronic temperature data loggers are installed at the validated hottest and coldest points within each shipping container to continuously record transport conditions.
  • Real-time temperature monitoring ensures full visibility throughout shipment.

Cold-Chain Validation

IX packaging systems are validated to maintain 2–8 °C for at least 72 hours under extreme ambient temperature conditions of 43 ± 1 °C or −20 ± 1 °C, in accordance with WHO cold-chain transport requirements.

Supply Chain Visibility & Traceability

Supply Chain Visibility & Traceability

IX applies digital management systems to maintain high visibility and control across the supply network.

Warehouse Management Systems (WMS & WCS)

  • Real-time inventory management
  • Improved operational efficiency and accuracy

Product Traceability System

  • End-to-end product traceability
  • Compliance with regulatory requirements
  • Each vaccine batch can be tracked from manufacturing to final delivery
Global Delivery Performance

Global Delivery Performance

IX works with internationally recognized logistics partners to ensure reliable vaccine distribution worldwide.
  • OTIF delivery performance (On-Time, In-Full)
  • Strict protection of product quality and integrity
  • Scalable logistics capacity for large-scale international supply programs
  • Responsive customer service and technical support
  • Distribution network supported by global logistics specialists, including DSV, DHL and World Courier

Over 80 million vaccine doses delivered to the global market.

Cecolin 9 for Public Cecolin 9 for HCPs Vaccine Portfolio Contact Us Media Report an Adverse Event
Copyright © 2026 Xiamen Innovax Biotech Co., Ltd. All rights reserved. 闽ICP备05033276号-3 闽公网安备 35020502000554号 Terms of Use Privacy Policy